NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
54 hedge funds and large institutions have $4.75M invested in Navidea Biopharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
54
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$22.3K | |
| 2 | +$14.6K | |
| 3 | +$13.8K | |
| 4 |
PP
PDS Planning
Dublin,
Ohio
|
+$13K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$9.02K |
Top Sellers
| 1 | -$54.9K | |
| 2 | -$31.9K | |
| 3 | -$24K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$22.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.2K |